Last reviewed · How we verify

NCT04053296

Long-term Outcomes of Pregnant Women With PAH

Status unknown Last updated 12 August 2019
What this trial tests

trial testing Observational study in Pulmonary Arterial Hypertension in 120 participants. Status unknown.

Timeline
1 November 2017
Primary endpoint
31 December 2019
31 December 2019

Quick facts

Lead sponsorRenJi Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment120
Start date1 November 2017
Primary completion31 December 2019
Estimated completion31 December 2019
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

RenJi Hospital

Who can join

18 and older, female only, with Pulmonary Arterial Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators intend to explore the characteristics and outcomes of pregnant women with PAH during different pregnancies and to provide applicable evidence for clinical practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Observational study

Trials testing the same drug.

Other recruiting trials for Pulmonary Arterial Hypertension

Currently open trials in the same condition.

Other RenJi Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04053296.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing